GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Feedback PLC (LSE:FDBK) » Definitions » EPS (Diluted)

Feedback (LSE:FDBK) EPS (Diluted) : £-0.26 (TTM As of Nov. 2023)


View and export this data going back to 1996. Start your Free Trial

What is Feedback EPS (Diluted)?

Feedback's Earnings per Share (Diluted) for the six months ended in Nov. 2023 was £-0.15. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2023 was £-0.26.

Feedback's EPS (Basic) for the six months ended in Nov. 2023 was £-0.15. Its EPS (Basic) for the trailing twelve months (TTM) ended in Nov. 2023 was £-0.26.

Feedback's EPS without NRI for the six months ended in Nov. 2023 was £-0.15. Its EPS without NRI for the trailing twelve months (TTM) ended in Nov. 2023 was £-0.26.

During the past 3 years, the average EPS without NRIGrowth Rate was 20.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 18.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was 8.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Feedback's highest 3-Year average EPS without NRI Growth Rate was 35.60% per year. The lowest was -37.30% per year. And the median was 13.60% per year.


Feedback EPS (Diluted) Historical Data

The historical data trend for Feedback's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Feedback EPS (Diluted) Chart

Feedback Annual Data
Trend May14 May15 May16 May17 May18 May19 May20 May21 May22 May23
EPS (Diluted)
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.58 -0.44 -0.32 -0.23 -0.22

Feedback Semi-Annual Data
May14 Nov14 May15 Nov15 May16 Nov16 May17 Nov17 May18 Nov18 May19 Nov19 May20 Nov20 May21 Nov21 May22 Nov22 May23 Nov23
EPS (Diluted) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -0.08 -0.10 -0.12 -0.15

Competitive Comparison of Feedback's EPS (Diluted)

For the Health Information Services subindustry, Feedback's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Feedback's PE Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Feedback's PE Ratio distribution charts can be found below:

* The bar in red indicates where Feedback's PE Ratio falls into.



Feedback EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Feedback's Diluted EPS for the fiscal year that ended in May. 2023 is calculated as

Diluted EPS (A: May. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-2.918-0)/13.335
=-0.22

Feedback's Diluted EPS for the quarter that ended in Nov. 2023 is calculated as

Diluted EPS (Q: Nov. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(-1.936-0)/13.335
=-0.15

EPS (Diluted) for the trailing twelve months (TTM) ended in Nov. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Feedback  (LSE:FDBK) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Feedback EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Feedback's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Feedback (LSE:FDBK) Business Description

Traded in Other Exchanges
Address
3-7 Temple Avenue, 201 Temple Chambers, London, GBR, EC4Y 0DT
Feedback PLC is a medical imaging software and tools company. It develops and markets imaging tools and software for clinical decision-making and also techniques and improved workflow for medical practitioners engaged in research and in treating patients. The company also entered into a joint venture for future clinical application of its products on patients with kidney stones and it has a medical imaging segment.

Feedback (LSE:FDBK) Headlines

No Headlines